News

  • Challenges, Opportunities and Facilitators in Implementing Personalised Medicine

    16 February 2024 – ICPerMed published three documents presenting a review of challenges and identified facilitators for personalised medicine implementation in healthcare practices formulated as recommendations.

    Read more


  • PROPHET Survey on Personalised Prevention

    26 January 2024 – To bridge the gap between the slower adoption of personalised prevention strategies compared to other approaches to personalised medicine, ICPerMed family member PROPHET invites stakeholders in personalised medicine to participate in a survey on the perceived barriers, challenges and enablers to the adoption of personalised prevention strategies in the EU and…

    Read more


  • ICPerMed Cooperation with EP PerMed

    26 January 2024 – ICPerMed members participated in the so-called Extended General Assembly of the European Partnership for Personalised Medicine (EP PerMed) on 24 January 2024 in Brussels. The new body brings together all ICPerMed and EP PerMed partners to ensure close collaboration between the two initiatives to promote the translation of personalised medicine into…

    Read more


  • EP PerMed JTC2024 Announcement

    02 January 2024 – The European Partnership for Personalised Medicine, EP PerMed, is launching the first Joint Transnational Call (JTC2024) for proposals on ‘Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)’.

    Read more

    EP PerMed Call Info

  • ICPerMed Workshop – Presentations and videos available

    19 December 2023 – Presentations of and videos taken during the ICPerMed Workshop ‘Advancing Personalised Medicine through Technology Development’ are now available.

    Read more


  • ERA PerMed Final Brochure published

    19 December 2023 – ERA PerMed has published its Final Brochure that summarises ERA PerMed’s activities and achievements with a focus on the research consortia funded in the first joint transnational call (JTC2018), co-funded by the European Union.

    Read more


  • HEcoPerMed Publication

    06 December 2023 – Researchers from the HEcoPerMed consortium published a special issue of Future Medicine / Personalised Medicine: VOLUME 20, ISSUE 4 / JULY 2023 with the following articles.

    Read more


  • EP PerMed Launch & Call Pre-Announcement

    04 December 2023 – The newly launched European Partnership for Personalised Medicine (EP PerMed) aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. With a total budget of around €375 million, provided by the EU and more than 50 international partners, EP PerMed will not only significantly support the transnational development…

    Read more

    Logo of the European Partnership for Personalised Medicine (EP PerMed)

  • IC2PerMed Roadmap published

    28 November 2023 – The IC2PerMed project has developed a Roadmap that encapsulates the project’s key findings and strategies to implement personalised medicine in the EU and China, emphasizing the exchange of best practices and addressing potential impediments. Through an extensive evaluation of personalised medicine landscapes in the EU and China, the project mapped existing…

    Read more


  • ICPerMed Workshop ‘Advancing Personalised Medicine through Technology Development’

    14 November 2023 – More than 90 healthcare professionals, leading experts and industry pioneers gathered for the 5th ICPerMed workshop on 14th and 15th November in Siena, Italy to discuss latest technology developments and the frontiers of personalised medicine innovation. The prestigious one and a half day event at the Museum Santa Maria della Scala…

    Read more

    Ejner Moltzen, ICPerMed Chair, at the opening of the ICPerMed workshop in Siena © Fabio di Pietro